Common Contracts
3 similar Management Agreement contracts by Cannabis Science, Inc.
MANAGEMENT AGREEMENTManagement Agreement • August 29th, 2013 • Cannabis Science, Inc. • Pharmaceutical preparations
THIS AGREEMENT (the "Agreement") effective as of the twentieth (20th) day of May 2013 (the “Effective Date”), entered into between Cannabis Science, Inc. a Nevada Corporation, with its principal offices located at 6946 North Academy Blvd Suite B #254, Colorado Springs, Colorado 80918 (the “Company” or “CBIS”) and IMMUNOCLIN LIMITED (a British company, owned 100% by Dr. Dorothy Helen Bray) with Limited with registered address at Rowlandson House, 289-293 Ballards Lane, London N12-8NP, United Kingdom(hereinafter, IMMUNOCLIN LIMITEDand its owner, Dr. Dorothy Helen Bray, are referred to as the “Consultant”) in connection with the provision of the Consultant’s services to the Company.
MANAGEMENT AGREEMENTManagement Agreement • August 29th, 2013 • Cannabis Science, Inc. • Pharmaceutical preparations
THIS AGREEMENT (the "Agreement") effective as of the Twenty-Fourth (24th) Day of June 2013 (the “Effective Date”), entered into between Cannabis Science, Inc., a Nevada Corporation, with its principal offices located at 6946 North Academy Blvd Suite B #254, Colorado Springs, Colorado 80918(along with its subsidiaries formed under Dutch law, unless otherwise specified, all herein referred to as the “Company”) and MLS LAP BV (a Dutch company, owned 100% by Mr. Mario Lap) with registered address at Koninginneweg 189, 1075 CP Amsterdam, The Netherlands(hereinafter, MLS LAP BV and its owner/director, Mr. Lap, are referred to as the “Consultant”) in connection with the provision of the Consultant’s services to the Company.
MANAGEMENT AGREEMENTManagement Agreement • June 17th, 2013 • Cannabis Science, Inc. • Pharmaceutical preparations
THIS AGREEMENT (the "Agreement") effective as of the twentieth (20th) day of May 2013 (the “Effective Date”), entered into between Cannabis Science, Inc. a Nevada Corporation, with its principal offices located at 6946 North Academy Blvd Suite B #254, Colorado Springs, Colorado 80918 (the “Company” or “CBIS”) and IMMUNOCLIN LIMITED (a British company, owned 100% by Dr. Dorothy Helen Bray) with Limited with registered address at Rowlandson House, 289-293 Ballards Lane, London N12-8NP, United Kingdom(hereinafter, IMMUNOCLIN LIMITEDand its owner, Dr. Dorothy Helen Bray, are referred to as the “Consultant”) in connection with the provision of the Consultant’s services to the Company.
